The statistics are worrying:

·  10% of all worldwide patients admitted in a hospital will acquire at least one healthcare-associated infection (HAI)¹
· Annually in the US, 2 million of patients gets infected in hospitals²
· 90.000 of them die²
· The estimated cost for the US Healthcare System is up to USD
  45 Billion^{2, 3}
· 50% of HAI’s at worldwide level are attributable to bacterial contamination of Medical Devices⁴
· >40% of Amputees present dermic complication due to High Bacterial Burden of Prosthetics and Orthotics⁵

1 World Health Organization (WHO)
2 Patricia W. Stone, Economic Burden of Healthcare-Associated Infections, An American Perspective.
3 Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention.
4 Kenawy, E., Worley, S. D., Broughton, R. 2007. The Chemistry and Applications of Antimicrobial Polymers: A State-of-the-Art Review.
5 (Dudek NL, 2005; Dudek NL, 2006; Maulenbelt HE, 2009)

This graphic shows the results of 2 studies conducted by microbiology laboratories in USA and Chile^1,2. Both studies confirm that the Colony Forming Units (CFU) of Staphylococcus aureus MRSA and Escherichia coli DH5α, falls abruptly during the first 6 hours of exposure to PLACTIVE (>95%), continuing the elimination of bacterial strains until reaching >98% elimination at 8 hours and >99.99% elimination at 24 hours.

1. SITU Biosciences Microbiology Laboratory, USA.
2. Microbiology Laboratory of Universidad Católica de Valparaíso, Chile.